Stage I Laryngeal Cancer AJCC v8
specificStage II includes: T2, N0, M0. T2: Supraglottis: Tumor invades the mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of the tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. M0:
28
Centers
28
Active Trials
—
Cancer Funding
Top Centers for Stage I Laryngeal Cancer AJCC v8(28)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 51.8 |
| 2 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 51.8 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 51.8 |
| 4 | NCI Comprehensive Active Research Program | 51.8 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.8 |
| 6 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 51.8 |
| 7 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.8 |
| 8 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 51.8 |
| 9 | NCI Comprehensive Active Research Program | 51.8 |
| 10 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.8 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.8 |
| 12 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 51.8 |
| 13 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 51.8 |
| 14 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.8 |
| 15 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 51.8 |
| 16 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program | 51.8 |
| 17 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.8 |
| 18 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 51.8 |
| 19 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.8 |
| 20 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.8 |
| 21 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.8 |
| 22 | Boston University Cancer CenterBoston, MA Active Research Program | 51.8 |
| 23 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 51.8 |
| 24 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.8 |
| 25 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.8 |
| 26 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.8 |
| 27 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 51.8 |
| 28 | Active Research Program | 51.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →